share_log
Reuters ·  May 3 05:20
Viking Therapeutics Shares Fall 5.2% Premarket; Amgen 'encouraged' by Its Weight-Loss Drug Interim Data
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment